Effect of supplement containing lutein on knee joint symptoms. -a randomized, double blind, placebo-controlled study

Not Applicable

• Conditions: Healthy volunteer

• Registration Number: JPRN-UMIN000021101
• Lead Sponsor: HUMA R&D CORP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-08-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects receiving treatment for pain of knee 2) Subjects receiving drug treatment 3) Subject receiving treatment for hyperuricemia 4) Subject receiving treatment or having a medical history for serious disease such as diabetes, cardiovascular disease, liver disease, kidney disease and heart disease 5) Subjects having rheumatism 6) Subjects having surgery of the knee or those who need knee surgery 7) Subjects having drug treatment plan for joint, during the test period 8) Subjects who has carried out the intra-articular injection of hyaluronic acid within two weeks, or the intra-articular injection of steroids within three months prior to the start of the present study 9) Subject having a medical history for disease related to bone and joints, such as fracture or sprain within three months 10) Subject taking lutein, salmon cartilage extract, proteoglycan, type 2 collagen, N-acetyl glucosamine, and other health food (hyaluronic acid, glucosamine, chondroitin sulfate, etc.) that might affect the evaluation of the test 11) Subject taking pharmaceutical products(especially glucosamine, chondroitin sulfate, vitamin D, containing amino acid, the drug treatment of osteoporosis) 12) Subject using a cane, routinely 13) Subject taking warfarin 14) Subject presenting known allergy to food or drug 15) For female subject: pregnancy or breast feeding, or possibility of pregnancy, or intention to be pregnant during the study 16) Subject deemed unsuitable by the investigator or test sharing doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified